
Phio Pharmaceuticals Corp. PHIO
$ 0.72
2.86%
Country |
|
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
5.98 M |
Market Cap[1] |
$ 4.31 M |
EBITDA (LTM) |
$ -15.2 M |
P/E (LTM) |
-0.669421 |
P/S (LTM) |
- |
EPS (LTM) |
-1.21 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
NextCure
NXTC
|
$ 6.87 | 2.54 % | $ 36.5 M | Nasdaq Global Select Market | ||
|
Rocket Pharmaceuticals
RCKT
|
$ 2.13 | 1.18 % | $ 237 M | Nasdaq Global Select Market | ||
|
PMV Pharmaceuticals
PMVP
|
$ 1.23 | 0.41 % | $ 64.6 M | Nasdaq Global Select Market | ||
|
Olema Pharmaceuticals
OLMA
|
$ 7.17 | -0.76 % | $ 624 M | Nasdaq Global Select Market | ||
|
Kymera Therapeutics
KYMR
|
$ 121.2 | -0.27 % | $ 10.2 B | Nasdaq Global Market | ||
|
Oragenics
OGEN
|
$ 0.19 | -7.43 % | $ 410 K | NYSE American | ||
|
Ovid Therapeutics
OVID
|
$ 2.26 | 1.58 % | $ 294 M | Nasdaq Global Select Market | ||
|
Passage Bio
PASG
|
$ 4.18 | -0.95 % | $ 13.4 M | Nasdaq Global Select Market | ||
|
Vaxcyte
PCVX
|
$ 58.53 | -1.47 % | $ 7.97 B | Nasdaq Global Select Market | ||
|
Relay Therapeutics
RLAY
|
$ 16.52 | 0.33 % | $ 2.83 B | Nasdaq Global Market | ||
|
Precigen
PGEN
|
$ 4.26 | -0.7 % | $ 1.33 B | Nasdaq Global Select Market | ||
|
Avidity Biosciences
RNA
|
$ 6.65 | 2.62 % | $ 916 M | Nasdaq Global Select Market | ||
|
Praxis Precision Medicines
PRAX
|
$ 306.58 | 0.5 % | $ 6.9 B | Nasdaq Global Select Market,SPB | ||
|
Prelude Therapeutics Incorporated
PRLD
|
$ 3.31 | -0.3 % | $ 255 M | Nasdaq Global Select Market | ||
|
ProQR Therapeutics N.V.
PRQR
|
$ 1.09 | -5.22 % | $ 115 M | Nasdaq Global Market | ||
|
Ocular Therapeutix
OCUL
|
$ 6.04 | 0.25 % | $ 1.13 B | Nasdaq Global Select Market | ||
|
Sana Biotechnology
SANA
|
$ 1.86 | -1.33 % | $ 471 M | Nasdaq Global Select Market | ||
|
Outlook Therapeutics
OTLK
|
$ 0.4 | 11.81 % | $ 13.9 M | Nasdaq Global Select Market | ||
|
United Therapeutics Corporation
UTHR
|
$ 577.46 | -1.14 % | $ 25.6 B | Nasdaq Global Select Market,SPB | ||
|
uniQure N.V.
QURE
|
$ 20.3 | -2.33 % | $ 1.17 B | Nasdaq Global Select Market | ||
|
Ultragenyx Pharmaceutical
RARE
|
$ 17.73 | 6.17 % | $ 1.75 B | Nasdaq Global Select Market,SPB | ||
|
Rafael Holdings
RFL
|
$ 0.95 | 3.48 % | $ 48.8 M | NYSE | ||
|
REGENXBIO
RGNX
|
$ 7.25 | 0.14 % | $ 374 M | Nasdaq Global Select Market,SPB | ||
|
Rigel Pharmaceuticals
RIGL
|
$ 42.57 | -0.82 % | $ 766 M | Nasdaq Global Select Market | ||
|
Celsion Corporation
CLSN
|
- | -6.63 % | $ 13.9 M | Nasdaq Capital Market | ||
|
Генетико
GECO
|
- | - | - | MOEX | ||
|
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market | ||
|
Tenax Therapeutics
TENX
|
$ 1.44 | 1.41 % | $ 56.5 M | Nasdaq Global Select Market | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | ||
|
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market | ||
|
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | ||
|
SELLAS Life Sciences Group
SLS
|
$ 18.42 | -3.84 % | $ 2.01 B | Nasdaq Capital Market | ||
|
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
- | 0.74 % | $ 768 M | Nasdaq Capital Market | ||
|
Abcam plc
ABCM
|
- | - | $ 4.9 B | Nasdaq Global Select Market | ||
|
Rezolute
RZLT
|
$ 4.26 | 5.98 % | $ 443 M | Nasdaq Capital Market | ||
|
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | ||
|
Tiziana Life Sciences PLC
TLSA
|
$ 0.8 | 23.73 % | $ 85.3 M | Nasdaq Global Market | ||
|
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market | ||
|
Affimed N.V.
AFMD
|
- | -34.95 % | $ 21.5 M | Nasdaq Global Select Market,SPB | ||
|
Vir Biotechnology
VIR
|
$ 9.14 | -1.24 % | $ 1.27 B | Nasdaq Global Select Market,SPB | ||
|
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
- | -1.58 % | $ 28.1 M | Nasdaq Global Market | ||
|
Celyad Oncology SA
CYAD
|
- | - | $ 12.5 M | Nasdaq Global Market | ||
|
Seer
SEER
|
$ 1.45 | -1.03 % | $ 80.4 M | Nasdaq Global Select Market | ||
|
Gracell Biotechnologies
GRCL
|
- | - | $ 3.37 B | Nasdaq Global Select Market | ||
|
Summit Therapeutics
SMMT
|
$ 10.49 | -1.73 % | $ 7.84 B | Nasdaq Global Select Market | ||
|
Viridian Therapeutics
VRDN
|
$ 30.1 | 0.13 % | $ 3.06 B | Nasdaq Capital Market | ||
|
Shattuck Labs
STTK
|
$ 4.48 | -2.4 % | $ 312 M | Nasdaq Global Select Market | ||
|
Silence Therapeutics plc
SLN
|
$ 19.82 | 0.08 % | $ 2.81 B | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.